MedPath

Characterisation of kinetics of biomarkers for cell ageing and resilience in geriatric tumorpatients after urooncological operations.

Conditions
C64
C67
Malignant neoplasm of kidney, except renal pelvis
Malignant neoplasm of bladder
Registration Number
DRKS00032874
Lead Sponsor
rologische und Kinderurologische Klinik, Uniklinikum Erlangen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
27
Inclusion Criteria

Planned radical Cystektomy or Kidney operation in curative intention

Exclusion Criteria

Age under 65 years, metastatic disease, neoadjuvant chemotherapy

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Functional deterioration, defined as ADL-reduction. Endpoint ist estimated 1, 3 and 6 months after operation.<br>
Secondary Outcome Measures
NameTimeMethod
Overall mortality
© Copyright 2025. All Rights Reserved by MedPath